Salma M. Aldallal (2023) “Ofatumumab as an Emerging Treatment Option for Chronic Lymphocytic Leukaemia Patients”, Research Highlights in Disease and Health Research Vol. 2, pp. 10–24. doi: 10.9734/bpi/rhdhr/v2/9253F.